Ultragenyx Pharmaceutical Inc.

RARENASDAQHealthcare● Active

$21.59

$-0.32(-1.46%)

Market Cap$2.1B

P/E Ratio—

52W High$42.37

52W Low$18.29

Avg Volume1.9M

Open$22.20

Beta0.38

Employees Ownership Insider Trades

Ultragenyx Pharmaceutical Inc. (RARE) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · RARE · as of Feb 18, 2026

Latest filing snapshot

1,371

+77+5.95%vs prior year

Ultragenyx Pharmaceutical Inc. (RARE) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

1,371

Change (1Y)

+77

Growth % (1Y)

+5.95%

Revenue / Employee

$490.9K

Net Income / Employee

$-419.4K

Market Cap

$2.1B

RARE Employee Count

2013 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-02-18	2025-12-31	1,371	+77	+5.95%
2025-02-19	2024-12-31	1,294	+18	+1.41%
2024-02-21	2023-12-31	1,276	-35	-2.67%
2023-02-17	2022-12-31	1,311	+192	+17.16%
2022-02-15	2021-12-31	1,119	+226	+25.31%
2021-02-12	2020-12-31	893	+153	+20.68%
2020-02-14	2019-12-31	740	+130	+21.31%
2019-02-20	2018-12-31	610	+90	+17.31%
2018-02-21	2017-12-31	520	+144	+38.30%
2017-02-17	2016-12-31	376	+127	+51.00%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

RARE

Ultragenyx Pharmaceutical Inc.YOU

1,371$2.1B #2

AAPG

Ascentage Pharma Group International

567$1.6B #3

APGE

Apogee Therapeutics, Inc.

196$5.1B #4

DYN

Dyne Therapeutics, Inc.

192$2.8B #5

CGON

CG Oncology, Inc. Common stock

Centessa Pharmaceuticals plc

77$6.1B

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · RARE peer comparison

About RARE employees

RARE Employees · Headcount

Ultragenyx Pharmaceutical Inc. (RARE) employee data is sourced from the annual SEC 10-K filing. As of 2025, Ultragenyx Pharmaceutical Inc. had 1,371 full-time employees globally. Full-time employees only. Global consolidated headcount.

Ultragenyx Pharmaceutical Inc. employs 1,371 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $490,883, reflecting the company's operational efficiency.

Ultragenyx Pharmaceutical Inc.'s workforce increased by 77 (5.95%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Ultragenyx Pharmaceutical Inc.'s revenue per employee of $490,883 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

RARE Employees · 5 questions

As of the latest SEC 10-K filing (2025), Ultragenyx Pharmaceutical Inc. had 1,371 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Ultragenyx Pharmaceutical Inc. employee counthow many employees does Ultragenyx Pharmaceutical Inc. haveRARE total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-18